These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9125900)

  • 1. [New approach for the studies on Alzheimer's disease: a beta 1-42 and acetylcholine].
    Hoshi M
    Seikagaku; 1997 Mar; 69(3):181-7. PubMed ID: 9125900
    [No Abstract]   [Full Text] [Related]  

  • 2. AβPP-Transgenic 2576 Mice Mimic Cell Type-Specific Aspects of Acetyl-CoA-Linked Metabolic Deficits in Alzheimer's Disease.
    Bielarczyk H; Jankowska-Kulawy A; Höfling C; Ronowska A; Gul-Hinc S; Roßner S; Schliebs R; Pawelczyk T; Szutowicz A
    J Alzheimers Dis; 2015; 48(4):1083-94. PubMed ID: 26402099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance, dyslipidemia, and apolipoprotein E interactions as mechanisms in cognitive impairment and Alzheimer's disease.
    Salameh TS; Rhea EM; Banks WA; Hanson AJ
    Exp Biol Med (Maywood); 2016 Sep; 241(15):1676-83. PubMed ID: 27470930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of lipid metabolism in Alzheimer's disease].
    Kamino K; Tanaka T; Kida T; Ohkochi M; Tanii H; Kudo T; Takeda M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Aug; 22(4):103-10. PubMed ID: 12373863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Memory impairment and cholinergic dysfunction by centrally administered Abeta and carboxyl-terminal fragment of Alzheimer's APP in mice.
    Choi SH; Park CH; Koo JW; Seo JH; Kim HS; Jeong SJ; Lee JH; Kim SS; Suh YH
    FASEB J; 2001 Aug; 15(10):1816-8. PubMed ID: 11481240
    [No Abstract]   [Full Text] [Related]  

  • 6. No evidence for cholinergic problems in apolipoprotein E knockout and apolipoprotein E4 transgenic mice.
    Bronfman FC; Tesseur I; Hofker MH; Havekens LM; Van Leuven F
    Neuroscience; 2000; 97(3):411-8. PubMed ID: 10828523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments.
    Ma J; Yee A; Brewer HB; Das S; Potter H
    Nature; 1994 Nov; 372(6501):92-4. PubMed ID: 7969426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nontoxic amyloid beta peptide 1-42 suppresses acetylcholine synthesis. Possible role in cholinergic dysfunction in Alzheimer's disease.
    Hoshi M; Takashima A; Murayama M; Yasutake K; Yoshida N; Ishiguro K; Hoshino T; Imahori K
    J Biol Chem; 1997 Jan; 272(4):2038-41. PubMed ID: 8999897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ApoE, amyloid, and Alzheimer's disease.
    Hardy J
    Science; 1994 Jan; 263(5146):454-5. PubMed ID: 8290946
    [No Abstract]   [Full Text] [Related]  

  • 10. [Molecular mechanism underlying the development of Alzheimer's disease: implications of apolipoprotein E and presenilin].
    Yanagisawa K
    Nihon Ronen Igakkai Zasshi; 2001 Jul; 38(4):455-7. PubMed ID: 11523146
    [No Abstract]   [Full Text] [Related]  

  • 11. Apolipoprotein E receptors: linking brain development and Alzheimer's disease.
    Herz J; Beffert U
    Nat Rev Neurosci; 2000 Oct; 1(1):51-8. PubMed ID: 11252768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E, A beta, and Alzheimer disease.
    Hyman BT; Terry RD
    J Neuropathol Exp Neurol; 1994 Sep; 53(5):427-8. PubMed ID: 8083685
    [No Abstract]   [Full Text] [Related]  

  • 13. Apolipoprotein E, A beta-amyloid, and the molecular pathology of Alzheimer's disease. Therapeutic implications.
    Kaplitt M; Gouras GK; Makimura H; Jovanovic J; Sweeney D; Greengard P; Relkin NR; Gandy S
    Ann N Y Acad Sci; 1996 Dec; 802():42-9. PubMed ID: 8993483
    [No Abstract]   [Full Text] [Related]  

  • 14. Amyloid beta-peptide 25-35 reduces [3H]acetylcholine release in retinal neurons. Involvement of metabolic dysfunction.
    Melo JB; Agostinho P; Oliveira CR
    Amyloid; 2002 Dec; 9(4):221-8. PubMed ID: 12557749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cholesterol and Alzheimer's disease].
    Kálmán J; Janka Z
    Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.
    Baker-Nigh A; Vahedi S; Davis EG; Weintraub S; Bigio EH; Klein WL; Geula C
    Brain; 2015 Jun; 138(Pt 6):1722-37. PubMed ID: 25732182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-β peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAβACs.
    Kumar R; Nordberg A; Darreh-Shori T
    Brain; 2016 Jan; 139(Pt 1):174-92. PubMed ID: 26525916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease: a central role for amyloid.
    Selkoe DJ
    J Neuropathol Exp Neurol; 1994 Sep; 53(5):438-47. PubMed ID: 8083687
    [No Abstract]   [Full Text] [Related]  

  • 19. [Amyloidogenicity and pathogenicity of Abeta43 in Alzheimer's disease].
    Saito T
    Seikagaku; 2013 Jul; 85(7):543-52. PubMed ID: 23980468
    [No Abstract]   [Full Text] [Related]  

  • 20. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro.
    Wisniewski T; Castaño EM; Golabek A; Vogel T; Frangione B
    Am J Pathol; 1994 Nov; 145(5):1030-5. PubMed ID: 7977635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.